Skip to main content
SRXH logo

SRXH · SRX Global Inc. · Investor Relations

Track SRXH — free
$0.80 -0.23 (-22.33%) At close · Nov 20 Play latest call Q3 2026 earnings call transcript
Market Cap
$16.21M
Shares
20.27M
Volume · Nov 20 1.09M Avg daily vol (3M) 605.02K

Press releases and events scraped from the company’s investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.

Recent news

Date Headline
2026-10-30 SRX Global Provides Update on Balance Sheet and Share Buyback
2026-10-26 SRX Global Announces Activation of the University of California, Davis as a Clinical Trial Site for CERo Therapeutics’ Ongoing Phase 1 CERTAIN-T Trial of CER-1236 in Hematologic Malignancies
2026-10-08 SRX Global Commits $2.5 Million to Launch Multi-Strategy Trading Platform in Partnership with 5T Trading, Powered by the EMJX Platform
2026-10-07 SRX Global and CERO 1236, a Wholly-Owned SPV, Enter into Definitive Agreement to Acquire CERo Therapeutics, an Innovative Cellular Immunotherapy Company Developing CER 1236 for Hematologic Malignancies
2026-10-06 SRX Global Commits $1.5 Million to Launch Family of AI-Powered ETFs through its EMJX Platform, Partnering with Kupa AI Co-Founder Andy Kim
2026-08-19 SRX GLOBAL INC. ANNOUNCES FISCAL THIRD QUARTER 2026 FINANCIAL RESULTS
2026-07-15 SRX Global Reports Paper-Traded EMJX Return of ~25% Since February 11, 2026
2026-07-10 SRX Global Management Team to Host Virtual Fireside Chat on July 14, 2026, and Issues Letter to Shareholders
2026-07-10 SRX Global Board of Directors Authorizes Stock Repurchase Plan of Up to 10 Million Shares or Up to 50% of its Shares Outstanding
2026-07-10 SRX Global Reports Preliminary Net Asset Value of Approximately $3.07 Per Share and Over $55 Million in Cash and Short-Term Investments 1
2026-07-10 SRX Global Declares One-Time Cash Dividend
2026-06-18 SRx Health Solutions Closes EMJX Acquisition and Launches AI-Driven Platform Strategy Under New Name and Brand, SRX Global, Focused on Investments in High-Conviction Operating Companies and Assets
2026-04-22 SRx Health Solutions Invests in Astro Investment XVII, an Affiliate of Astro Capital
2026-04-17 SRx Health Solutions and EMJX Issue Letter to Shareholders from Eric M. Jackson
2026-02-12 SRx Health Solutions Redeems Series A Preferred Stock and Cancels Approximately 125,000,000 Shares of Common Stock, Improving Balance Sheet Flexibility for Investment in M&A or Return of Capital to Shareholders
2025-12-16 SRx Health Enters into Definitive Agreement to Acquire EMJX to Establish Next-Generation Digital Asset Treasury Operating System and Platform Led by Eric M. Jackson

Past events

Source: https://www.srxhealth.com/

Key facts CIK 1471727 CUSIP 08771Y501 13F (30d) 26 filings 21 filers Visit website Investor relations